Research Paper Volume 15, Issue 13 pp 6526—6544
N6AMT1 is a novel potential diagnostic, prognostic and immunotherapy response biomarker in pan-cancer
Figure 2. Differential expression and clinical relevance of N6AMT1 in 33 tumor types. (A) Differential expression of N6AMT1 in pan-cancer. (B) N6AMT1 expression in pan-cancer order from high to low. Correlations of N6AMT1 expression with patient age (C), gender (D) and tumor stage (E). *: p < 0.05, **: p < 0.01, ***: p < 0.001. ns: No Significant.